Align 3-phosphoshikimate 1-carboxyvinyltransferase (EC 2.5.1.19) (characterized)
to candidate WP_029908949.1 P166_RS0103900 3-phosphoshikimate 1-carboxyvinyltransferase
Query= BRENDA::Q83E11 (438 letters) >NCBI__GCF_000711315.1:WP_029908949.1 Length = 448 Score = 432 bits (1111), Expect = e-125 Identities = 233/444 (52%), Positives = 305/444 (68%), Gaps = 14/444 (3%) Query: 1 MDYQTIPSQGLSGEICVPGDKSISHRAVLLAAIAEGQTQVDGFLMGADNLAMVSALQQMG 60 + + P L G I VPGDKS+SHR+++L +IAEG T+V GFL G D+LA + A + MG Sbjct: 5 VQFHVKPGGVLKGRIRVPGDKSVSHRSIMLGSIAEGTTRVTGFLEGEDSLATLQAFKDMG 64 Query: 61 ASIQVIEDENILVVEGVGMTGLQAPPEALDCGNSGTAIRLLSGLLAGQPFNTVLTGDSSL 120 I+ + N+ + GVG+ GL+ P LD GNSGTA+RL++G+LAGQ F L GD+SL Sbjct: 65 VQIEGPDQGNV-TIHGVGLRGLKKPSNPLDMGNSGTAMRLMAGILAGQDFECTLIGDASL 123 Query: 121 QRRPMKRIIDPLTLMGAKIDST-GNVPPLKIYGNPRLTGIH---YQLPMASAQVKSCLLL 176 +RPMKR+ PL+ MGA ID+ G +PPL + P TG++ Y LPMASAQVKSC+LL Sbjct: 124 SKRPMKRVTQPLSEMGADIDTAEGGMPPLHL--KPTKTGLNAIDYTLPMASAQVKSCVLL 181 Query: 177 AGLYARGKTCITEPAPSRDHTERLLKHFHYTLQKDKQS-----ICVSGGGKLKANDISIP 231 AGLYA G T + EPAP+RDHTER+LK F Y ++ +K + + GGG LKA DI +P Sbjct: 182 AGLYANGTTSVVEPAPTRDHTERMLKGFGYDVKTEKLDSMQTRVELKGGGVLKAMDIDVP 241 Query: 232 GDISSAAFFIVAATITPGSAIRLCRVGVNPTRLGVINLLKMMGADIEVTHYTEKNEEPTA 291 DISSAAFF+VAA I P + + + VG+NPTR GVI++LK+MGADI + + + EP A Sbjct: 242 SDISSAAFFMVAAAIAPEADLVIEHVGINPTRTGVIDILKLMGADITLENESTVGGEPVA 301 Query: 292 DITVRHARLKGIDIPPDQVPLTIDEFPVLLIAAAVAQGKTVLRDAAELRVKETDRIAAMV 351 DI V+ ++LKGI IP VPL IDEFPVL +AAA A+G+TVL A ELRVKE+DRI M Sbjct: 302 DIHVKSSKLKGIKIPEALVPLAIDEFPVLFVAAAAAEGQTVLTGAEELRVKESDRIQVMA 361 Query: 352 DGLQKLGIAAESLPDGVIIQGGTLEG--GEVNSYDDHRIAMAFAVAGTLAKGPVRIRNCD 409 D L +GI A+ PDG++I GG + G +NS+ DHRI+MA VAG A + I +C Sbjct: 362 DALIAVGIDAQPTPDGMVINGGQQKSQVGGINSHHDHRISMAMTVAGLNAVDDIVIDDCA 421 Query: 410 NVKTSFPNFVELANEVGMNVKGVR 433 NV TSFP FV+L N++GM V V+ Sbjct: 422 NVNTSFPTFVQLVNQIGMTVNVVK 445 Lambda K H 0.318 0.137 0.392 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 640 Number of extensions: 43 Number of successful extensions: 5 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 438 Length of database: 448 Length adjustment: 32 Effective length of query: 406 Effective length of database: 416 Effective search space: 168896 Effective search space used: 168896 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.7 bits) S2: 51 (24.3 bits)
Align candidate WP_029908949.1 P166_RS0103900 (3-phosphoshikimate 1-carboxyvinyltransferase)
to HMM TIGR01356 (aroA: 3-phosphoshikimate 1-carboxyvinyltransferase (EC 2.5.1.19))
# hmmsearch :: search profile(s) against a sequence database # HMMER 3.3.1 (Jul 2020); http://hmmer.org/ # Copyright (C) 2020 Howard Hughes Medical Institute. # Freely distributed under the BSD open source license. # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - # query HMM file: ../tmp/path.aa/TIGR01356.hmm # target sequence database: /tmp/gapView.2705836.genome.faa # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Query: TIGR01356 [M=415] Accession: TIGR01356 Description: aroA: 3-phosphoshikimate 1-carboxyvinyltransferase Scores for complete sequences (score includes all domains): --- full sequence --- --- best 1 domain --- -#dom- E-value score bias E-value score bias exp N Sequence Description ------- ------ ----- ------- ------ ----- ---- -- -------- ----------- 4e-131 423.6 0.6 4.5e-131 423.4 0.6 1.0 1 NCBI__GCF_000711315.1:WP_029908949.1 Domain annotation for each sequence (and alignments): >> NCBI__GCF_000711315.1:WP_029908949.1 # score bias c-Evalue i-Evalue hmmfrom hmm to alifrom ali to envfrom env to acc --- ------ ----- --------- --------- ------- ------- ------- ------- ------- ------- ---- 1 ! 423.4 0.6 4.5e-131 4.5e-131 1 414 [. 17 439 .. 17 440 .. 0.95 Alignments for each domain: == domain 1 score: 423.4 bits; conditional E-value: 4.5e-131 TIGR01356 1 geikipgsKSishRalllaaLaegetvvtnlLkseDtlatlealrklGakve.eekeelviegvgg..lkepe 70 g+i++pg+KS+shR+++l+++aeg+t+vt++L++eD latl+a++++G+++e ++++++i+gvg lk p+ NCBI__GCF_000711315.1:WP_029908949.1 17 GRIRVPGDKSVSHRSIMLGSIAEGTTRVTGFLEGEDSLATLQAFKDMGVQIEgPDQGNVTIHGVGLrgLKKPS 89 79**************************************************76799******99888***** PP TIGR01356 71 aeldlgnsGttaRlltgvlalasgevvltgdeslkkRPierlveaLrelgaeieskeeegslPlaisgplkg. 142 + ld+gnsGt++Rl+ g+la +++e++l gd sl+kRP++r++++L+e+ga+i+ +e g +Pl+++ +++g NCBI__GCF_000711315.1:WP_029908949.1 90 NPLDMGNSGTAMRLMAGILAGQDFECTLIGDASLSKRPMKRVTQPLSEMGADIDTAE-GGMPPLHLKPTKTGl 161 ******************************************************988.69********96666 PP TIGR01356 143 .givelsgsaSsQyksalllaaplalqavtleivgeklisrpyieitLkllksfgveveeede..rkivvkgg 212 +i + ++aS+Q+ks++lla+ l a++++ v e+ +r+++e++Lk ++ + v+ e+ d+ +++ +kgg NCBI__GCF_000711315.1:WP_029908949.1 162 nAIDYTLPMASAQVKSCVLLAG---LYANGTTSVVEPAPTRDHTERMLKGFGYD-VKTEKLDSmqTRVELKGG 230 8999******************...55667777777****************88.999998885566677777 PP TIGR01356 213 qkykqkevevegDaSsAafflaaaaitge.evtvenlgenstqgdkaiiivLeemGadveveeqr........ 276 + k +++v++D+SsAaff++aaai++e ++++e++g+n+t+++ +i++L+ mGad+++e+++ NCBI__GCF_000711315.1:WP_029908949.1 231 GVLKAMDIDVPSDISSAAFFMVAAAIAPEaDLVIEHVGINPTRTG--VIDILKLMGADITLENEStvggepva 301 7777779**************************************..788*********************** PP TIGR01356 277 dvevegasklkgvkv.didvdsliDelptlavlaafAegetriknieelRvkEsdRiaaiaeeLeklGvevee 348 d+ v+ +sklkg+k+ ++ v+ +iDe+p+l v+aa Aeg+t+++++eelRvkEsdRi+++a++L ++G+++++ NCBI__GCF_000711315.1:WP_029908949.1 302 DIHVK-SSKLKGIKIpEALVPLAIDEFPVLFVAAAAAEGQTVLTGAEELRVKESDRIQVMADALIAVGIDAQP 373 *****.799******99******************************************************** PP TIGR01356 349 ledgllieGkkkelkgavvdtydDHRiamalavlglaaegeveiedaecvaksfPeFfevleqlga 414 ++dg++i+G++++ + + +++++DHRi ma++v+gl a + + i+d + v++sfP F+++++q+g+ NCBI__GCF_000711315.1:WP_029908949.1 374 TPDGMVINGGQQKSQVGGINSHHDHRISMAMTVAGLNAVDDIVIDDCANVNTSFPTFVQLVNQIGM 439 **********999999**********************************************9975 PP Internal pipeline statistics summary: ------------------------------------- Query model(s): 1 (415 nodes) Target sequences: 1 (448 residues searched) Passed MSV filter: 1 (1); expected 0.0 (0.02) Passed bias filter: 1 (1); expected 0.0 (0.02) Passed Vit filter: 1 (1); expected 0.0 (0.001) Passed Fwd filter: 1 (1); expected 0.0 (1e-05) Initial search space (Z): 1 [actual number of targets] Domain search space (domZ): 1 [number of targets reported over threshold] # CPU time: 0.01u 0.01s 00:00:00.02 Elapsed: 00:00:00.00 # Mc/sec: 18.89 // [ok]
This GapMind analysis is from Jul 25 2024. The underlying query database was built on Jul 25 2024.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory